Gene Logic Says Value of Assets from TherImmune Acquisition is Impaired, Lowers Revenue Expectations for Unit | GenomeWeb

NEW YORK, Sept. 23 (GenomeWeb News) - Gene Logic said yesterday that the value of the goodwill asset from its 2003 acquisition of TherImmune Research is impaired.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.